{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:26:13Z","timestamp":1793597173421,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.seizure.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:40:29Z","timestamp":1763462429000},"page":"192-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Letter on Dwivedi et al. 2015: Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2236-8615","authenticated-orcid":false,"given":"Vikt\u00f3ria","family":"\u010eur\u010dov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Pe\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-6711","authenticated-orcid":false,"given":"Jan","family":"Ju\u0159ica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-8711","authenticated-orcid":false,"given":"Marta","family":"Pelcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Gregorov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8610-5601","authenticated-orcid":false,"given":"Pavel","family":"\u0160mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2025.07.005_bib0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.seizure.2014.10.010","article-title":"Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy","volume":"25","author":"Dwivedi","year":"2015","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2025.07.005_bib0002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5649\/jjphcs.31.217","article-title":"TDM using salivary VPA levels in saliva samples taken at patients\u2019 Homes (1)","volume":"31","author":"Saito","year":"2005","journal-title":"Iryo Yakugaku (Jpn J Pharm Health N Hav Care Sci)"},{"issue":"4","key":"10.1016\/j.seizure.2025.07.005_bib0003","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jps.2600730415","article-title":"Use of hexadeuterated valproic acid and gas chromatography-mass spectrometry to determine thePharmacokinetics of valproic acid","volume":"73","author":"Acheampong","year":"1984","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.seizure.2025.07.005_bib0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0920-1211(02)00251-6","article-title":"Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy","volume":"53","author":"Cloyd","year":"2003","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.seizure.2025.07.005_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007691-198612000-00005","article-title":"Variable free and total valproic acid concentrations in sole- and multi-drug therapy","volume":"8","author":"Cramer","year":"1986","journal-title":"Ther Drug Monit."},{"issue":"5","key":"10.1016\/j.seizure.2025.07.005_bib0006","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/01.ftd.0000245376.85777.8a","article-title":"Measuring unbound versus total valproate concentrations for therapeutic drug monitoring","volume":"28","author":"Sproule","year":"2006","journal-title":"Ther Drug Monit."},{"issue":"1","key":"10.1016\/j.seizure.2025.07.005_bib0007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0b013e31827c11e7","article-title":"Therapeutic drug monitoring of antiepileptic drugs by use of saliva","volume":"35","author":"Patsalos","year":"2013","journal-title":"Ther Drug Monit."},{"key":"10.1016\/j.seizure.2025.07.005_bib0008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.seizure.2018.04.012","article-title":"Determinants of free serum valproate concentration: a prospective study in patients on divalproex sodium monotherapy","volume":"59","author":"Nasreddine","year":"2018","journal-title":"Seizure - Eur J Epilepsy"},{"key":"10.1016\/j.seizure.2025.07.005_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/217269","article-title":"Hyperammonemia Associated with Valproic Acid Concentrations","volume":"2014","author":"V\u00e1zquez","year":"2014","journal-title":"BioMed Res Int"},{"issue":"6","key":"10.1016\/j.seizure.2025.07.005_bib0011","first-page":"378","article-title":"HPLC determination of valproic acid in human serum","volume":"58","author":"Kishore","year":"2003","journal-title":"Pharmazie"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125001773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125001773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:27:11Z","timestamp":1793593631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131125001773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":10,"alternative-id":["S1059131125001773"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2025.07.005","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter on Dwivedi et al. 2015: Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}